Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,121 | -155,636 | -70,024 | -58,080 | -21,512 |
| Depreciation Amortization | 646 | 2,773 | 2,106 | 1,441 | 734 |
| Accounts receivable | -1,379 | -9,704 | -5,231 | -326 | -881 |
| Accounts payable and accrued liabilities | 1,523 | -452 | 113 | -786 | -236 |
| Other Working Capital | -328 | 1,175 | -5,329 | -3,069 | -4,193 |
| Other Operating Activity | -20,942 | 108,290 | 31,057 | 27,170 | 7,234 |
| Operating Cash Flow | $-17,359 | $-53,554 | $-47,308 | $-33,650 | $-18,854 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -158 | -841 | -588 | -374 | -249 |
| Investing Cash Flow | $-158 | $-841 | $-588 | $-374 | $-249 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 3,201 | 3,201 | 3,201 | N/A |
| Debt Repayment | -2,083 | -3,201 | -3,201 | -3,201 | 0 |
| Common Stock Issued | 922 | 228,014 | 64,101 | 63,881 | 12,818 |
| Other Financing Activity | -1 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-1,162 | $228,014 | $64,101 | $63,881 | $12,818 |
| Beginning Cash Position | 229,821 | 56,201 | 56,201 | 56,201 | 56,201 |
| End Cash Position | 211,142 | 229,821 | 72,406 | 86,058 | 49,916 |
| Net Cash Flow | $-18,679 | $173,620 | $16,205 | $29,857 | $-6,285 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,359 | -53,554 | -47,308 | -33,650 | -18,854 |
| Capital Expenditure | -158 | -841 | -588 | -374 | -249 |
| Free Cash Flow | -17,517 | -54,395 | -47,896 | -34,024 | -19,103 |